Physician profile
Raymond Shea
NPI 1336171479
$248.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $42.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $58.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.57 | 2019-2020 | |
| Stryker Corporation | $31.24 | 2019 | |
| Ferring Pharmaceuticals INC. | $22.02 | 2019 | |
| Orthogenrx INC. | $17.95 | 2019 | |
| Dynasplint Systems INC. | $17.55 | 2019 | |
| Pacira Therapeutics, INC. | $15.28 | 2019 | |
| Bioventus LLC | $13.95 | 2019 | |
| Depuy Synthes Sales INC. | $13.25 | 2020 | |
| Flowonix Medical Incorporated | $11.61 | 2019 | |
| Zyla Life Sciences, INC. | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.